Moly crisis to continue as AECL pushes reactor restart to 2010

Aug 12, 2009

Nuclear medicine physicians may have to wait a little longer for the shortage of the radioisotope molybdenum-99 to abate. Atomic Energy of Canada (AECL) has pushed back the anticipated restart of its Chalk River, Ontario, nuclear reactor to the first quarter of 2010.

Click here to read the rest of the article.

New H3 Tracers Thumbnail

SNMMI: New PET tracers developed for imaging brain disorders

June 21, 2025

Alzheimer's Case Study

Alzheimer's Case Study

June 6, 2025

Positrigo closes $8.5M funding round

June 10, 2025

Pxl 20250531 175048475~2

Radium-223 safety confirmed in long-term study

June 2, 2025

SNMMI: New PET tracers developed for imaging brain disorders

Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and psychiatric conditions.

June 21, 2025

New H3 Tracers Thumbnail

Ratio Therapeutics partners with Macrocyclics

By AuntMinnie.com staff writers

The agreement will enable access to Macropa in Japan, Canada, Australia, and a majority of Europe, according to Ratio.

June 13, 2025

Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400

Positrigo closes $8.5M funding round

By AuntMinnie.com staff writers

Firm also notes board changes.

June 10, 2025

Radium-223 safety confirmed in long-term study

By Erik L. Ridley

At ASCO 2025, researchers shared data on the long-term safety of Ra-223 treatments for metastatic castration-resistant prostate cancer.

June 2, 2025

Pxl 20250531 175048475~2

Clarity highlights first patient imaged in Amplify trial

By AuntMinnie.com staff writers

Clarity Pharmaceuticals has imaged the first patient in its phase III Amplify trial at XCancer in Omaha, NE.

May 29, 2025

Prostate Cancer 3 D Rendering 400 (1)

ITM forges $263M debt financing agreement

By AuntMinnie.com staff writers

Isotope Technologies Munich (ITM) has entered into a debt financing agreement for up to $262.5 million.

May 28, 2025

ISMRM: AI spots ischemic heart disease on low GBCA dose images

By Erik L. Ridley

An AI-based framework was highly accurate for detecting myocardial ischemia, even on images acquired with 90% less gadolinium.

May 14, 2025

Representative stress perfusion CMR case with 80% contrast dose reduction. Pixel-wise MBF maps and AHA 16-segment bull's eye plots are shown for full-dose and reduced-dose acquisitions. When analyzed using the proposed MST deep learning method, the reduced-dose data closely matches the full-dose data across basal, mid, and apical slices. In contrast, Fermi-deconvolution shows good agreement in apical and mid slices but overestimates MBF in some basal segments, indicating reduced accuracy under low-dose conditions. Image courtesy of the ISMRM.

FDA clears GE's new dual-head SPECT/CT system

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared GE HealthCare's (GEHC) new dual-head SPECT/CT system, Aurora.

May 5, 2025

Controversy clouds nuclear medicine bill

Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.

May 1, 2025

ARRS: 'Neurotheranostics' may be new frontier for nuclear medicine

Advances in brain PET imaging combined with new treatments for Alzheimer’s have given rise to a new concept of "neurotheranostics."

April 29, 2025

A conceptual framework for neurotheranostics.

ARRS: Rib uptake evaluation on F-18 DCFPyL PET/CT presents challenges

By Maryam Payne

Evaluating increased rib uptake on F-18 DCFPyL PET/CT in prostate cancer patients may lead to false positives.

April 28, 2025

Eckert & Ziegler signs manufacturing deal with Pentixapharm

By AuntMinnie.com staff writers

Eckert & Ziegler Radiopharma GmbH has signed a manufacturing agreement with Pentixapharm.

April 24, 2025

Manufacturing Facility Process

Page 1 of 438